How are we doing
- Financial reports
- AIM Rule 26
- Securities and Shareholder Information
- Regulatory news
- Company information
- Constitutional Documents
- Corporate governance
The Company’s historical financial statements are set out in the Admission Document.
The Annual Report and accounts of the Company will be made up to 30 November in each year with copies expected to be sent to Shareholders within the following five months.
The first annual report is prepared to 30 November 2021. The Company will also publish unaudited half-yearly reports to 31 May each year with copies expected to be posted to Shareholders within the following three months.
The first unaudited half-yearly report is prepared to 31 May 2022. The Company’s financial statements will be prepared and presented in Sterling under IFRS.
2025 Annual Report and Notice of AGM
24.04.2026
2025 Interim Report
13.08.2025
2024 Annual Report and Notice of AGM
18.03.2025
2024 Interim Report
31.07.2024
2023 Annual Report and Notice of AGM
08.05.2024
2023 Interim Report
31.08.2023
2022 Annual Report and notice of AGM
03.05.2023
2022 Interim Report
05.08.2022
2021 Annual Report and notice of AGM
26.04.2022
Please find the below information disclosed pursuant of Rule 26 of the AIM Rules
This information was last updated 24th April 2026.
| Description | Link |
|---|---|
| Admission Document and Circulars | Can be viewed here |
| Business Description | Can be viewed here |
| Company Directors and Biographies | Can be viewed here |
| Country of Incorporation and Operations | Country of incorporation: England and Wales Company registration number: 12398098 Main country of operation: United Kingdom |
| Details of the nominated adviser and other key advisers | Can be viewed here |
| Details of the Board and Corporate Governance | Can be viewed here |
| Corporate documents | Can be viewed here |
| Financial Reports and Results | Can be viewed here |
| Details of any other exchanges or trading platforms on which the company has applied or agreed to have any of its securities (Including AIM securities) admitted and traded | The company has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms other than its admission to trading on AIM with trading code AIM:LST |
| Major Shareholders | Can be viewed here |
| Regulatory News | Can be viewed here |
| Takeover Code | The Company is subject to the provisions of the City Code on Takeover and Mergers |
Click on the documents below to view/download the PDF
Final Results, Analyst and Investor Presentations
24/04/2026
Holding(s) in Company
17/04/2026
Holding(s) in Company
17/04/2026
Notice of Results, Analyst Briefing, Investor Pres
17/04/2026
Holding(s) in Company
16/04/2026
Holding(s) in Company
15/04/2026
Holding(s) in Company
15/04/2026
Holding(s) in Company
15/04/2026
Completion of Acquisitions
15/04/2026
Holding(s) in Company
14/04/2026
Holding(s) in Company
14/04/2026
Holding(s) in Company
14/04/2026
Result of General Meeting & Total Voting Rights
09/04/2026
BSR Strategic Plan: Implications for PFP
09/04/2026
Holding(s) in Company
02/04/2026
Total Voting Rights
31/03/2026
Agtech Contract Wins
30/03/2026
Holding(s) in Company
20/03/2026
Holding(s) in Company
18/03/2026
Result of Retail Offer
17/03/2026
Result of Placing
11/03/2026
Launch of Retail Offer
11/03/2026
Acquisitions and Fundraise to raise up to £6.6m
11/03/2026
AgTech – UK Parliamentary Group Calls for Action
03/11/2025
AgTech Contract Win
27/10/2025
AgTech Update
15/10/2025
PFP Division Secures BSA Accreditation
29/09/2025
Holding(s) in Company
25/09/2025
Holding(s) in Company
16/09/2025
Contract Wins
26/08/2025
Holding(s) in Company
20/08/2025
Holding(s) in Company
20/08/2025
Holding(s) in Company
18/08/2025
Holding(s) in Company
15/08/2025
CEM Contact Wins
15/08/2025
Holding(s) in Company
14/08/2025
Interim Results
13/08/2025
Notice of Results, Analyst Briefing, Investor Presentation
05/08/2025
Holding(s) in Company
07/07/2025
Holding(s) in Company
07/07/2025
Additional endorsement of Injectaclad’s durability
17/06/2025
Appointment of Nominated Adviser and Broker
16/06/2025
AgTech Update
02/06/2025
Result of AGM
15/04/2025
PFP Division – UK Dangerous Cladding Report
24/03/2025
Final Results & Notice of AGM
18/03/2025
Notice of Results, Analyst Briefing, Investor Presentation
12/03/2025
Capital Markets Day & Retail Investor Presentation
26/02/2025
Holding(s) in Company
14/02/2025
UK and European Distribution Agreement
10/02/2025
Holding(s) in Company
07/02/2025
Holding(s) in Company
07/02/2025
Capital Markets Day & Retail Investor Presentation
29/01/2025
Holding(s) in Company
20/01/2025
Holding(s) in Company
20/01/2025
Director Dealings
09/12/2024
Trading Update
04/12/2024
Mello Presentation
14/11/2024
Holding(s) in Company
24/10/2024
Passive Fire Protection Update
21/10/2024
Further Sports Entertainment Order
12/09/2024
Holding(s) in Company
09/09/2024
Passive Fire Protection Division Update
09/09/2024
Holding(s) in Company
03/09/2024
Holding(s) in Company
29/08/2024
Holding(s) in Company
23/08/2024
Holding(s) in Company
21/08/2024
Contract Electronics Manufacturing Division Update
20/08/2024
New CEA Contract
13/08/2024
Interim Results
31/07/2024
Notice of Results, Analyst Briefing, Investor Pres
30/07/2024
Holding(s) in Company
29/07/2024
Holding(s) in Company
29/07/2024
Contract Electronics Manufacturing Division Update
22/07/2024
Holding(s) in Company
10/07/2024
Trading Update
04/07/2024
Holding(s) in Company
20/06/2024
PFP Contract Win Worth in Excess of £750,000
19/06/2024
Result of AGM
31.05.2024
Holding(s) in Company
10.05.2024
Director Dealing
10.05.2024
South Africa Distributor Agreement
09.05.2024
Final Results & Notice of AGM
08.05.2024
Business Update, Notice of Results & Investor Presentation
30.04.2024
Award of Product Development Grant Funding
22.03.2024
Holding(s) in Company
14.03.2024
Holding(s) in Company
12.03.2024
Board Changes and Issue of Share Options
07.03.2024
New Order in a New Market
08.02.2024
Holding(s) in Company
22.01.2024
Trading Update
10.01.24
Acquisition of Injecta Fire Barrier
21.11.2023
Holding(s) in Company
09.11.2023
Grant of Options
12.10.2023
Holding(s) in Company
10.10.2023
Expansion of CEA Division’s Global Reach
05.10.2023
Award of Grant Funding
22.09.2023
Holding(s) in Company
07.09.2023
Investor Presentation
07.09.2023
Acquisition of Tomtech
06.09.2023
Holding(s) in Company
31.08.2023
Half-Year Report
31.08.2023
Holding(s) in Company
17.08.2023
Holding(s) in Company
03.08.2023
Change of Registered Office
28.07.2023
Trading Update
29.06.2023
Result of AGM
30.05.2023
Holding(s) in Company
09.05.2023
Change of Broker
05.05.2023
Final Results, Board Changes & Notice of AGM
03.05.2023
Notice of Results & Investor Presentation
27.04.2023
Holding(s) in Company
26.04.2023
Holding(s) in Company
25.04.2023
Holding(s) in Company
24.04.2023
Result of General Meeting & TVR
21.04.2023
Result of Fundraising and WRAP Retail offer
18.04.2023
Holding(s) in Company
06.04.2023
Posting of Circular
05.04.2023
Wrap retail offer for up to £0.5 million
05.04.2023
Proposed £1.5 million Placing and Subscription
04.04.2023
Appointment of joint broker
27.01.2023
Trading update
02.12.2022
Additional sensorGROW trials and nurturGROW update
08.11.2022
Rentokil Contract Extension and SensorGROW trials
29.09.2022
Zenith Contract Update and UKRI Grant Update
16.09.2022
Q3 Trading update
18.08.2022
Interim results
05.08.2022
Expansion of nurturGROW range & CEM update
23.06.2022
Official launch of sensorGROW
16.06.2022
Trading update
10.06.2022
Director dealing
24.05.2022
Result of AGM
19.05.2022
Notice of AGM and Posting of Annual Report
29.04.2022
2021 Annual Results
26.04.2022
Notice of Results & Investor Presentation
20.04.2022
Director Dealing
28.03.2022
Funding Update & Strengthening of CEA Division
15.02.2022
Director/PDMR Shareholding – Acquisition of Shares
01.12.2021
Investor presentation webinar
25.11.2021
Vox markets presentation
16.11.2021
Zenith and Rentokil Contracts Update
08.11.2021
Holding(s) in Company
03.11.2021
Placing of Existing Shareholder’s Interest
03.11.2021
Holding(s) in Company
18.10.2021
Admission to trading on AIM & First Day of Dealings
15.10.2021
Intention to float on AIM
12.10.2021
This information was last updated on 24th April 2026.
The Company was incorporated in England and Wales on 13 January 2020 and is the holding company of the Group’s three divisions:
- Passive fire protection (“PFP”) division, comprising Injectaclad Ltd (“Injectaclad”), following its acquisition on 14 April 2026, and LSTH IFB Limited t/a Injecta Fire Barrier (“Injecta Fire Barrier”), following the acquisition of its trade and assets on 21 November 2023;
- Contract electronics manufacturing (“CEM”) division, comprising UK Circuits and Electronics Solutions Limited (“UK Circuits”);
- AgTech (“AGT”) division, comprising Light Science Technologies Ltd (“Light Science Technologies”) and following its acquisition on 6 September 2023, Tomtech (UK) Limited (“Tomtech”).
The Company’s registered office address is The Mills, Canal Street, Derby, DE1 2RJ, United Kingdom and the company registration number is 12398098.
Injectaclad was founded in 2020 and following its acquisition is based in Derby, England with distribution and training facilities in Manchester, England. It owns the intellectual property for a unique remediation system for missing or defective building cavity fire barriers, retrospectively installed via a patented pumped method, without the need for full building façade removal. The system is distributed through a network of QA-approved contractors and is backed by extensive independent testing and UL-EU 3rd party accreditation. The Injectaclad acquisition enhances the Group’s PFP division by adding proprietary technology that complements Injecta Fire Barrier’s installation expertise.
Injecta Fire Barrier is based in Derby, England and serves as an approved installer of the Injectaclad fire resistant cavity barrier system. The system is retrospectively installed within building cavities to reinstate fire compartmentation, containing the spread of fire and smoke in line with fire safety regulations. This solution provides a cost-effective alternative to full façade removal and traditional fire barriers. Injecta Fire Barrier has a proven track record in the PFP market, now complemented by the Group’s ownership of Injectaclad.
UK Circuits was founded in 1997 and is a contract electronics manufacturer with solid revenue and cash generation. The Group’s manufacturing facilities in Manchester, England enable the Group to design, manufacture and test high-quality CEM products, serving a broad range of sectors.
Light Science Technologies was founded in September 2019 and facilitates the Company’s AGT operations. The Group’s operational facilities in Derby, England, enable the Group to design, test and provide innovative Agtech products and services.
Tomtech was founded in 1986 and subsequently incorporated in 2011, complementing Light Science Technologies within the Company’s AGT operations. Tomtech is based in Spalding, England, and designs, manufactures and installs monitoring and control systems for commercial greenhouses and polytunnels across the UK and Ireland.
Nominated and Financial Adviser to the Company
Shore Capital and Corporate Limited
Cassini House, 57 St James’s Street, London, SW1A 1LD
Legal Adviser to the Company
Shoosmiths LLP
One Bow Churchyard, London, EC4M 9DQ, United Kingdom
Registrar to the Company
Neville Registrars Limited
Neville House, Steelpark Road, Halesowen, B62 8HD, United Kingdom
Broker to the Company
Shore Capital Stockbrokers Limited
Cassini House, 57 St James’s Street, London, SW1A 1LD
Financial public relations adviser
Walbrook PR Limited
75 King William Street, London, EC4N 7BE, United Kingdom
Click on the documents below to view/download the PDF
This information was last updated 24th April 2026.
Updated corporate governance statement
24.04.25
Circular
13.03.26
Updated corporate governance statement
17.03.25
Updated corporate governance statement
06.03.24
Updated terms of reference – remuneration committee
06.03.24
Updated terms of reference – audit and risk committee
06.03.24
Updated terms of reference – nomination committee
06.03.24
Updated corporate governance statement
29.06.2023
Updated terms of reference – remuneration committee
29.06.2023
Updated terms of reference – audit and risk committee
29.06.2023
Updated terms of reference – nomination committee
29.06.2023
Circular
05.04.2023
Admission document
15.10.2021
Corporate governance statement
14.10.2021
Schedule of matters reserved for the board
11.10.2021
Terms of reference – remuneration committee
09.10.2021
Terms of reference – audit and risk committee
09.09.2021
Terms of reference – nomination committee
09.09.2021
Articles of Association
01.07.2021
Corporate governance
The Board is committed to the principles of good corporate governance and believes that an effective corporate governance framework is essential to underpin the success of the Group’s business. The Board is committed to achieving the highest standards of integrity, ethics, professionalism and business practice throughout the Group’s operations. Therefore, the Company has adopted the Quoted Companies Alliance Corporate Governance Code (the “QCA Code”), in line with the AIM Rules for Companies, which requires all AIM-quoted companies to adopt a recognised corporate governance code and to explain how the company complies with and where it departs from the chosen code. Click here for details and refer to page 18 onwards of the 2025 Annual Report.
Graham Cooley (Chairman) – 24th April 2026
Board members responsibilities
The Board is responsible for the overall management of the Group. The Board will meet at least 6 times a year and otherwise on an as-required basis, to review, formulate and approve the Group’s strategy, budgets, corporate actions and oversee the Group’s progress towards its goals.
The key procedures which the Board has established with a view to providing effective internal financial control include the following:
– the Company has instituted a monthly management reporting process to enable the Board to monitor the performance of the Company;
– the Board has adopted and reviewed a comprehensive annual budget for the Company. Monthly results will be examined against the budget and deviations will be closely monitored by the Board; and
– the Board is responsible for maintaining and identifying major business risks faced by the Company and for determining the appropriate courses of action to manage those risks.
The Company has established an Audit and Risk Committee, a Remuneration Committee, and a Nomination Committee, each with formally delegated duties and responsibilities and with written terms of reference. From time to time, separate committees may be set up by the Board to consider specific issues when the need arises.
There is a clear separation of the roles of Chairman and Chief Executive Officer.
The Chairman is responsible for the running of the Board and has ultimate responsibility for corporate governance matters. With guidance from the Company’s advisers, the Chairman will assess the appropriateness of the Company’s governance structures as the Group continues to develop. The Company is committed to the evolution of its corporate governance in line with best practice, and following recent updates to the QCA Code has or intends to implement a variety of minor amendments to current practices, including enhancement to the risk management and sustainability activities, and implementing a more formal board effectiveness review and succession planning process
The Chief Executive Officer is ultimately responsible for the day-to-day running of the business and implementing the Board’s strategy and decisions.
Board Effectiveness Review and Succession planning
The Board intends to review its performance within the coming months and annually thereafter by conducting a self-review questionnaire covering a variety of areas, including the skills the Board possesses; the effectiveness with which the committees carry out their duties; and other aspects of the governance processes and structure. The Company’s financial performance, stakeholder feedback, and other sources of information are also used in the evaluation. This has evolved from the prior year where reviews were more informal in nature. The Board considers an externally facilitated review to be a valuable tool for driving continuous improvement and will supplement its internal review process in the coming years with an externally facilitated review, as the size and nature of the Group develops.
The results and planned actions will be reviewed and agreed when the nomination committee meets later in the year, this review will coincide with consideration of the Company’s succession planning for board and divisional leadership appointments
Stakeholder feedback
The Board recognises the importance of corporate social responsibility as critical to the Group’s long-term success and seeks continued engagement with the Company’s stakeholders, through direct contact by the executive or senior management team feedback from key stakeholders is obtained
Given the size and early stage of the Agtech and Passive Fire Protection divisions’ operations, the Board is very familiar with the Group’s operations as well as the industries, enabling the Board to clearly identify key resources and relationships on which the Group relies, this includes employees, customers and suppliers. As a result of feedback from such stakeholders, actions have been taken to improve service levels and integrate into the innovative products in development.
The Chief Financial Officer will be the primary contact for shareholders and there is a dedicated e-mail address for shareholder questions and comments shareholders@lightsciencetech.com.
Audit and Risk Committee
The audit and risk committee comprises Richard Mills and Graham Cooley, and is chaired by Richard Mills.
The audit and risk committee is responsible for monitoring the integrity of the Company’s financial statements, reviewing significant financial reporting issues, reviewing the effectiveness of the Company’s internal control and risk management systems, monitoring the need for and if necessary the effectiveness of the internal audit function and overseeing the relationship with the external auditors including advising on their appointment, agreeing the scope of the audit and reviewing the audit findings.
The audit committee meets at least three times a year at appropriate times in the reporting and audit cycle and otherwise as required. The audit committee meets regularly with the Company’s external auditors.
Remuneration Committee
The remuneration committee is comprised of Richard Mills and Graham Cooley, and is chaired by Richard Mills.
The remuneration committee is responsible for determining and agreeing with the Board the policy for the remuneration of the Chief Executive Officer, the other executive Directors and other designated senior executives and, within the terms of the agreed policy, determining the total individual remuneration packages of such persons including, where appropriate, bonuses, incentive payments and share options or other share awards.
The remuneration of non-executive Directors is a matter for the executive members of the Board. No Director is involved in any decision as to his or her own remuneration. The remuneration committee meets at least twice a year and otherwise as required.
Nominations Committee
The nominations committee is comprised of Graham Cooley, Richard Mills and Simon Deacon, and is chaired by Graham Cooley.
The nominations committee is responsible for reviewing the structure, size and composition of the Board and identifying and nominating, for the approval of Board, candidates to fill vacancies on the Board as and when they arise. The nominations committee meets at least twice a year and otherwise as required.



